Comprehensive support in designing, implementing, and optimizing drug programs, including therapy effectiveness and cost analyses.

We conduct system analyses of the organization and financing of medical technologies in Poland and international markets, including recommendations on funding for new therapies.

Complete reimbursement dossiers for medicines and medical devices, including clinical and economic effectiveness analyses.

We develop applications and AI solutions for physicians, patients, as well as pharmaceutical and MedTech company departments. Our tools support treatment, real-world data (RWD) analysis, and scientific communication, while our training programs ensure the safe and effective use of AI.

Precise cost analyses of medical technologies (both direct and indirect) and Time & Motion studies that measure the time and resources required to deliver healthcare services. This data supports informed financial, organizational, and reimbursement decisions.

Comprehensive support in Market Access, HTA, and HEOR across CEE markets. Access to the European HTA Database – a comprehensive repository of HTA documents from across Europe, supporting preparations for EU HTA and local reimbursement processes.

Expert support in oncology projects — clinical and market analyses, RWD studies, training, and value communication strategies. Our team, including practicing clinicians, combines medical expertise with extensive experience in Market Access and HTA.

Cost and reimbursement process analysis for medical devices, supporting their market entry and negotiations with payers.

Organizing training in HTA, Market Access, and reimbursement, as well as preparing materials for scientific publications and conference presentations.